{"title":"An Overview of Contemporary and Future Therapeutic Strategies for Scalp Psoriasis.","authors":"Bindu Soni, Riya Shivgotra, Karan Trehan, Aashveen Chhina, Muskaan Saini, Subheet Kumar Jain, Shubham Thakur","doi":"10.2174/0113894501292755240304063020","DOIUrl":null,"url":null,"abstract":"<p><p>Scalp psoriasis is a common manifestation of psoriasis that significantly impacts a patient's quality of life. About 80% of cases of psoriasis involve the scalp, making it the most frequently affected area of the body. The treatment of scalp psoriasis is particularly crucial because of its hard-to-treat nature and substantial adverse impacts on overall well-being. Along with the physical symptoms of discomfort and itching, psoriasis, especially when it affects the scalp, can cause severe psychological damage. Treating scalp psoriasis can be challenging due to its location and associated symptoms, such as scaling and pruritus, which is why various drugs have become widely used for refractory cases. Topical treatments like corticosteroids and vitamin D analogs manage scalp psoriasis by reducing inflammation and regulating skin cell growth. Tar-based shampoos, salicylic acid solutions, and moisturizers control scaling. Phototherapy with UVB light reduces inflammation. Severe cases may require systemic medications such as oral retinoids and immunosuppressants. While various therapies are accessible for scalp psoriasis, concerns arise due to their limited advantages and the absence of controlled studies assessing their effectiveness. Considering these challenges, there is a clear demand for innovative approaches to address this condition effectively. Recent advancements in topical therapies, phototherapy, systemic agents, and complementary therapies have shown promising results in managing scalp psoriasis. Also, the advent of biologics, specifically anti-IL-17 and anti-IL-23 drugs for scalp psoriasis, has seen significant improvements. The review highlights the lack of well-tolerated and effective treatments for scalp psoriasis and underscores the importance of further research in this area. The objective of this review is to clarify the different treatment options currently available or being investigated in clinical trials for managing scalp psoriasis.</p>","PeriodicalId":10805,"journal":{"name":"Current drug targets","volume":" ","pages":"353-373"},"PeriodicalIF":3.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113894501292755240304063020","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
Scalp psoriasis is a common manifestation of psoriasis that significantly impacts a patient's quality of life. About 80% of cases of psoriasis involve the scalp, making it the most frequently affected area of the body. The treatment of scalp psoriasis is particularly crucial because of its hard-to-treat nature and substantial adverse impacts on overall well-being. Along with the physical symptoms of discomfort and itching, psoriasis, especially when it affects the scalp, can cause severe psychological damage. Treating scalp psoriasis can be challenging due to its location and associated symptoms, such as scaling and pruritus, which is why various drugs have become widely used for refractory cases. Topical treatments like corticosteroids and vitamin D analogs manage scalp psoriasis by reducing inflammation and regulating skin cell growth. Tar-based shampoos, salicylic acid solutions, and moisturizers control scaling. Phototherapy with UVB light reduces inflammation. Severe cases may require systemic medications such as oral retinoids and immunosuppressants. While various therapies are accessible for scalp psoriasis, concerns arise due to their limited advantages and the absence of controlled studies assessing their effectiveness. Considering these challenges, there is a clear demand for innovative approaches to address this condition effectively. Recent advancements in topical therapies, phototherapy, systemic agents, and complementary therapies have shown promising results in managing scalp psoriasis. Also, the advent of biologics, specifically anti-IL-17 and anti-IL-23 drugs for scalp psoriasis, has seen significant improvements. The review highlights the lack of well-tolerated and effective treatments for scalp psoriasis and underscores the importance of further research in this area. The objective of this review is to clarify the different treatment options currently available or being investigated in clinical trials for managing scalp psoriasis.
头皮银屑病是银屑病的一种常见表现,严重影响患者的生活质量。约 80% 的银屑病病例涉及头皮,因此头皮是人体最常受影响的部位。由于头皮银屑病难以治疗,而且会对整体健康产生严重的负面影响,因此治疗头皮银屑病尤为重要。除了身体上的不适和瘙痒症状外,银屑病(尤其是头皮银屑病)还会造成严重的心理伤害。由于头皮银屑病的发病部位和相关症状(如脱屑和瘙痒),治疗头皮银屑病具有挑战性,因此各种药物被广泛用于治疗难治性头皮银屑病。皮质类固醇激素和维生素 D 类似物等外用疗法通过减轻炎症和调节皮肤细胞生长来控制头皮银屑病。焦油类洗发水、水杨酸溶液和保湿剂可控制脱屑。紫外线光疗可减轻炎症。严重的患者可能需要口服维甲酸和免疫抑制剂等全身性药物。虽然头皮银屑病可以采用多种疗法,但由于这些疗法的优势有限,而且缺乏评估其有效性的对照研究,因此引起了人们的关注。考虑到这些挑战,显然需要创新的方法来有效解决这一问题。近年来,局部疗法、光疗、全身用药和辅助疗法在治疗头皮银屑病方面取得了长足的进步。此外,生物制剂的出现,特别是治疗头皮银屑病的抗IL-17和抗IL-23药物,也带来了显著的改善。综述强调了头皮银屑病缺乏耐受性好且有效的治疗方法,并强调了在这一领域开展进一步研究的重要性。本综述旨在阐明目前可用于治疗头皮银屑病或正在临床试验中研究的不同治疗方案。
期刊介绍:
Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes.
Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies.
As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.